Evoke Pharma Inc (EVOK)
4.35
-0.15
(-3.33%)
USD |
NASDAQ |
Nov 22, 16:00
4.21
-0.14
(-3.22%)
After-Hours: 18:23
Evoke Pharma Revenue (Quarterly): 2.654M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.654M |
| June 30, 2024 | 2.551M |
| March 31, 2024 | 1.736M |
| December 31, 2023 | 1.676M |
| September 30, 2023 | 1.563M |
| June 30, 2023 | 1.131M |
| March 31, 2023 | 0.8104M |
| December 31, 2022 | 0.7964M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.8321M |
| June 30, 2022 | 0.4618M |
| March 31, 2022 | 0.4184M |
| December 31, 2021 | 0.3606M |
| September 30, 2021 | 0.9304M |
| June 30, 2021 | 0.2366M |
| March 31, 2021 | 0.0904M |
| December 31, 2020 | 0.023M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.023M
Minimum
Dec 2020
2.654M
Maximum
Sep 2024
1.017M
Average
0.8213M
Median
Revenue (Quarterly) Benchmarks
| Repligen Corp | 154.87M |
| Eli Lilly and Co | 11.44B |
| MEI Pharma Inc | -- |
| Revance Therapeutics Inc | 59.88M |
| NovaBay Pharmaceuticals Inc | 2.441M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.312M |
| Total Expenses (Quarterly) | 3.940M |
| EPS Diluted (Quarterly) | -0.94 |
| Enterprise Value | 0.348M |
| Gross Profit Margin (Quarterly) | 96.08% |
| Profit Margin (Quarterly) | -49.45% |
| Earnings Yield | -253.6% |
| Normalized Earnings Yield | -253.56 |